Side-by-Side Comparison
| Metric | Genelux | HiberCell |
|---|---|---|
| Founded | ||
| Founded | 2001 older | 2019 |
| Headquarters | ||
| Headquarters | Westlake Village, United States | New York, United States |
| Employees | ||
| Employees | 34 | 25 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Unknown |
| Total Funding | ||
| Total Funding | $98.98M | $128.20M |
| Funding Rounds | ||
| Funding Rounds | 5 | 2 |
| Services | ||
| Services | Development of oncolytic immunotherapy, Clinical trial management, Expanded access programs | Development of therapeutic candidates (HC-7366, HC-5404), Clinical-stage research and trials, Exploiting stress-driven vulnerabilities in cancer cells |
| Target Customers | ||
| Target Customers | Cancer patients, Healthcare professionals, Clinical researchers | Cancer patients, Healthcare providers, Biotech investors, Oncologists |
| Taxonomy | ||
| Taxonomy | Oncolytic Immunotherapy, Solid Tumors, Cancer Treatment, Clinical-stage Biotech, Viral Therapy, Immunotherapies, Clinical Trials, Cancer Research, Cancer Therapy, Personalized Medicine | Oncology, Therapeutics, Cancer, Metastasis, Clinical Stage, Adaptive Stress Pathways, Anti-tumor Immunity, Product Candidates, Phase 1a Clinical Trials, Cancer Relapse Prevention, New York, Treatment Resistance, Stress Response Kinases, Innate Immune Response |
| Website | ||
| Website | genelux.com | hibercell.com |
About Genelux
Genelux Corporation (NASDAQ: GNLX) is a late clinical-stage biotechnology firm founded in 2001 and based in the United States. The company operates at the forefront of the Biopharma, Biotechnology, and Health Care industries, focusing on oncolytic immunotherapy to improve patient outcomes in cases o...
About HiberCell
HiberCell, founded in 2019 and headquartered in the United States, is a pioneering force in the Biotechnology and Health Care industries. With a focus on developing novel therapeutics, the company aims to prevent cancer relapse and metastasis. Its slogan, "Developing Novel Therapeutics to Prevent Ca...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Genelux and HiberCell — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Genelux and HiberCell — by email.
Frequently Asked Questions
Compare Genelux with someone else
Start typing a company name or domain.